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Diabetes is a metabolic disorder in which the body
fails to produce enough insulin. Type 1 diabetes is
the result of an autoimmune process, which
leaves the patient dependent on insulin injections
for survival.1 The incidence of type 1 diabetes is
much lower than that of type 2 diabetes, but the
earlier onset and higher degree of glycemic ex-
posure in type 1 diabetes place patients at a
substantial risk for serious morbidities and earlier
than expected mortality.2
Autonomic neuropathy is a common compli-
cation of diabetes. Extensive involvement of the
autonomic nervous system in diabetic patients
produces a variety of physiologic changes, which
may include the electrical and contractile activity of
the myocardium.3 In patients with type 1 diabetes,
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Background/Purpose: Type 1 diabetes is commonly associated with autonomic neuropathy. The present
study investigated the influences of glycemic control, disease duration (DD), and exercise on autonomic
nervous function in children with type 1 diabetes by analysis of their heart rate variability (HRV).
Methods: Seventy-nine type 1 diabetic children were recruited and categorized into four groups by HbA1c
of 8% and DD of 4.5 years. HRV parameters as determined by separate frequency domain components
(low frequency: LnLF, 0.04–0.15 Hz; high frequency: LnHF, 0.15–0.5 Hz; total power: LnTP, 0.04–0.5 Hz)
were measured both at rest and during exercise. Pearson’s correlation, one-way ANOVA, and multiple 
regressions with stepwise method were used for statistical analysis.
Results: While at rest, HbA1c and DD were negatively correlated with all HRV parameters. Both HbA1c
and DD were significant predictors in LnTP. However, only HbA1c was a significant predictor in LnLF and
LnHF. Type 1 diabetes patients with HbA1c > 8% and DD > 4.5 years had a significantly lower HRV than
the other patients. During exercise, HRV reduced significantly and no significant correlation between
HbA1c and HRV or between DD and HRV was observed. Also, a significant difference in HRV among the
four groups was not demonstrated. The smallest decrement in HRV from resting to exercise were in subjects
with HbA1c > 8% and DD > 4.5 years.
Conclusion: HbA1c was a more dominant predictor for LnTP, LnHF and LnLF than DD in children with
type 1 diabetes at rest. HRV reduced significantly from resting to exercise. However, the responses of HRV
during exercise differ from the responses of HRV at rest. [J Formos Med Assoc 2007;106(11):935–942]
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subclinical signs of cardiovascular autonomic
neuropathy (CAN) were detectable in 20–36% of
individuals.4 Once the diagnosis of CAN is estab-
lished, a high mortality rate ranging from 27% to
56% will ensue.5,6
Heart rate variability (HRV) has been widely ap-
plied to assess autonomic nervous function by ana-
lyzing the frequency components of oscillation in
RR intervals of electrocardiography (ECG).7 With
regard to HRV parameters, high frequency (HF;
0.15–0.5Hz) mainly reflects parasympathetic nerv-
ous activities; low frequency (LF; 0.04–0.15 Hz)
reflects chiefly sympathetic and a friction of para-
sympathetic nervous activities; while total power
(TP; 0.04–0.5 Hz) represents overall autonomic
nervous activities.8 Abnormal HRV can be detected
in diabetic subjects even when the clinical signs
of CAN are obscure.9–13 HRV analysis has been
demonstrated to be more sensitive than traditional
cardiovascular reflex tests in the clinical evaluation
of autonomic nervous function.9,10,14,15
The pathogenesis of CAN in diabetes remains
poorly understood. Neural damage by chronic
hyperglycemia, vascular insufficiency, and au-
toimmune mechanisms have been suggested as
plausible causes.16–18 A previous study has demon-
strated that extended disease duration (DD) and
poor glycemic control are related to diminished
HRV in type 1 diabetes.11,13 However, the concur-
rent effects of glycemic control and DD on HRV
have not been addressed. In addition, exercise is
usually advocated for diabetic patients, but little is
known about the change in HRV during exercise
in type 1 diabetes. The purpose of this study was
to determine the impacts of glycemic control and
DD on HRV parameters at the same time. In ad-
dition, the response of HRV during exercise in
children with type 1 diabetes was also examined.
Materials and Methods
Subjects and grouping
Seventy-nine subjects aged 8–13 years with type 1
diabetes were recruited from a pediatric diabetic
clinic in a tertiary medical center in Taiwan. Type 1
diabetes was diagnosed on the basis of clinical
and laboratory evidence. Patients presented with
polyuria, polydipsia, and weight loss with/without
polyphagia. They had hyperglycemia (glucose
> 200 mg/dL) and ketosis with/without acidosis.
Those who had acanthosis nigricans, hemato-
logic disorders, Prader-Willi syndrome or Turner
syndrome and those who were taking steroid or
growth hormone therapy were excluded. Anti-islet
autoantibodies including glutamic acid decarboxy-
lase and insulinoma-associated antigen-2 were also
measured in all enrolled children. In the study, all
subjects were receiving regular insulin treatments.
This study was approved by the human investiga-
tion committee of the hospital, and written in-
formed consent was obtained from all subjects
and their parents before their participation.
HbA1c tested within 1 month and DD were
obtained from the medical charts. In terms of 
the recommendation of the American Diabetes
Association, HbA1c of school-aged diabetic chil-
dren should be ≤ 8%.19 Therefore, the adequacy
of glycemic control was determined by the cut-
off value of 8%. All subjects had a DD ranging
from 1.0 to 12.0 years, and we adopted 4.5 years,
the median of our study group, as the dividing
point for grouping. Subjects were then cate-
gorized into group I (n = 16, HbA1c ≤ 8%, DD ≤
4.5 years), group II (n = 15, HbA1c ≤ 8%, DD > 4.5
years), group III (n = 21, HbA1c > 8%, DD ≤ 4.5
years), and group IV (n = 27, HbA1c > 8%, DD >
4.5 years).
HRV analysis
Standard three-channel ECG electrodes were at-
tached to the anterior chest wall of subjects and
connected to the monitor system (Acqknowledge
III, MP150WSW; BIOPAC System, Santa Barbara,
CA, USA). All QRS complexes from ECG were
first edited automatically and then manually by
careful inspection of the RR intervals. Signals were
digitalized at 500 Hz and transformed into a spec-
trum by Fast Fourier Transformation. Separate fre-
quency components of the HRV were obtained
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including LF, HF and TP. These HRV parameters
were then logarithmically transformed (Ln) to
control for the skewed distributions.
Experimental protocol
All procedures were performed in a quiet room,
with the temperature maintained at 21–26°C. At
the study entrance, the age, gender, body height,
body weight, body mass index (BMI), waist/hip
ratio (WHR), HbA1c, and DD were documented.
Beverages rich in caffeine content and vigorous
exercise were prohibited in the 2 hours before
testing. The ECG was recorded at rest and during
exercise. All subjects were asked to stand still for
10 minutes at rest, followed by exercise with a
fixed rhythm on a stair-stepper (JK-355c; JKexer
Inc., Taipei, Taiwan) for 10 minutes. ECG was
continuously monitored throughout the test. HRV
analysis was based on the last 5 minutes of record-
ings of the steady ECG in each section.
Statistical analysis
SPSS version 12.0 (SPSS Inc., Chicago, IL, USA)
for Windows was used for data analysis. Data were
expressed as mean ± standard deviation (SD).
Pearson’s correlation was used to examine the rela-
tionships between HRV and HbA1c or DD. Dif-
ferences in HRV among the four groups were
determined by one-way ANOVA. Post hoc analysis
for multiple comparisons of means was performed
using Scheffé’s test. Multiple regressions with
stepwise method were conducted to determine
the predictors of HRV. A p value < 0.05 was con-
sidered statistically significant.
Results
Seventy-nine children (37 males, 42 females)
with type 1 diabetes participated in this study.
The overall mean age was 10.3 ± 1.3 years. The av-
erage body height and weight were 137.0 ± 9.4 cm
and 34.7 ± 8.6 kg, respectively. Mean BMI was
18.3 ± 3.2 kg/m2, and mean WHR was 0.8 ± 0.1.
HbA1c ranged between 6.3% and 17.2%, with
a mean of 9.3 ± 2.4%. DD ranged between 1.0
and 12.0 years, with a mean of 4.2 ± 2.6 years.
Of the 79 children, 65 (82.3%) were positive for
at least one of the measured autoantibodies. No
significant difference in gender, age, body height,
body weight, BMI, and WHR was observed among
the four groups (Table 1).
The mean HbA1c and DD were 7.2 ± 0.5%
and 2.1 ± 1.2 years for group I, 7.5 ± 0.5% and
6.5 ± 1.4 years for group II, 10.4 ± 2.3% and
2.4 ± 1.2 years for group III, and 10.9 ± 2.2%
and 6.8 ± 1.8 years for group IV, respectively.
Impact of HbA1c and DD on HRV
There were significant negative correlations 
between HbA1c and all HRV parameters at 
rest in children with type 1 diabetes (Figure 1).
The estimated regression equations were y = 7.64 −
0.16x (r=−0.46, p<0.001) in LnLF, y = 6.71 − 0.18x
Influencing factors on HRV in type 1 DM
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Table 1. Characteristics of subjects*
Variables Group I (n = 16) Group II (n = 15) Group III (n = 21) Group IV (n = 27) p
Gender (M/F) 6/12 8/5 11/15 12/10 0.36
Age (yr) 9.6 ± 1.0 9.7 ± 1.5 10.1 ± 1.2 10.6 ± 1.4 0.08
Height (cm) 137.3 ± 9.0 135.5 ± 9.2 138.2 ± 9.4 136.2 ± 10.1 0.82
Weight (kg) 35.9 ± 9.6 33.5 ± 8.9 35.7 ± 8.6 33.1 ± 7.7 0.64
BMI (kg/m2) 18.9 ± 3.7 18.0 ± 2.4 18.5 ± 3.5 17.7 ± 2.9 0.63
WHR 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.2 0.49
HbA1c (%) 7.2 ± 0.5 7.5 ± 0.5 10.4 ± 2.3 10.9 ± 2.2
Disease duration (yr) 2.1 ± 1.2 6.5 ± 1.4 2.4 ± 1.2 6.8 ± 1.8
*Data are presented as mean ± standard deviation or n. BMI = body mass index; WHR = waist/hip ratio.
(r = −0.39, p < 0.001) in LnHF, and y = 8.33 − 0.14x
(r = −0.53, p < 0.001) in LnTP. However, no signif-
icant correlations were observed during exercise
for LnLF (r = −0.14, p = 0.20), LnHF (r = −0.16,
p = 0.16), or LnTP (r= −0.09, p= 0.41).
There were negative correlations between
LnHF and DD as well as LnTP and DD, but not
between LnLF and DD in children with type 1
diabetes at rest (Figure 2). The estimated regres-
sion equations were y = 5.51 − 0.09x (r = −0.23,
p = 0.039) in LnHF and y = 7.34 − 0.14x (r = −0.27,
p = 0.018) for LnTP. During exercise, no significant
correlation between DD and any HRV parameters
could be demonstrated.
To determine the concurrent effects of gly-
cemic control and DD on HRV parameters, a series
of multiple regressions with stepwise method
were performed. Only HbA1C was a significant
predictor in LnHF (F = 13.831, p < 0.0001) and
LnLF (F = 20.808, p < 0.0001) (Table 2). Both
HbA1C and DD were significant predictors in
LnTP (F = 18.370, p < 0.0001). No significant rela-
tionship between HbA1c and DD (r = 0.1,
p = 0.38) was observed in this study.
Comparison of HRV at rest and during
exercise among groups
The HRV of the four study groups both at rest
and during exercise are shown in Figure 3. While
at rest, LnLF was significantly lower in group IV
than in groups I, II and III (5.5 ± 0.9 vs. 6.6 ± 0.5,
6.4 ± 0.7 and 6.3 ± 0.6, respectively). Similar results
were obtained for LnHF (4.3 ± 0.9 vs. 5.9 ± 0.9,
5.4 ± 1.0 and 5.9 ± 0.9, respectively) and LnTP
(6.6 ± 0.6 vs. 7.6 ± 0.4, 7.2 ± 0.5 and 7.2 ± 0.4,
respectively).
All HRV parameters during exercise were lower
than they were at rest. No significant differences
in HRV parameters were demonstrated during
exercise among the four study groups. However,
the percentage of decrease from resting to exercise
in LnLF, LnHF and LnTP was smaller in group IV
S.R. Chen, et al
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(27%, 51% and 26%, respectively) than in group I
(35%, 51% and 30%, respectively), group II (38%,
59% and 32%, respectively), and group III (38%,
64% and 32%, respectively).
Discussion
Our data showed that HRV parameters, includ-
ing LnLF, LnHF and LnTP, were all negatively cor-
related with HbA1c in type 1 diabetic children at
rest, suggesting that autonomic nervous function
was adversely affected by poor glycemic control.
These findings are in agreement with previous
research by Rollins et al who reported a negative
correlation between HbA1c and HRV in type 1
diabetes.20 It was also found that patients with
type 1 diabetes were less likely to develop abnor-
mal RR interval variations if they received inten-
sive glycemic control.21 Although Wawryk et al
reported a contradictory result that reduced HRV
was not associated with short-term or long-term
metabolic control, they conceded that their sub-
jects were relatively well controlled, which possibly
Influencing factors on HRV in type 1 DM
J Formos Med Assoc | 2007 • Vol 106 • No 11 939
Table 2. Stepwise regression analysis of heart rate variability
Dependent variable Independent variable B Beta Adjusted accumulated R2 t
LnTP HbA1C −0.132 −0.508 0.270 −5.365*
Disease duration −0.050 −0.216 0.308 −2.280†
LnHF HbA1C −0.175 −0.390 0.141 −3.719*
LnLF HbA1C −0.161 −0.461 0.203 −4.562*
*p < 0.0001; †p < 0.05.
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Figure 2. Correlation between disease duration and heart
rate variability parameters at rest in children with type 1 
diabetes: (A) LnLF; (B) LnHF; (C) LnTP.
dimmed their correlation.11 CAN in diabetes is
thought to occur at least in part due to the effect
of hyperglycemia through the accumulation of
reduced sugars in diabetic nerves. The neuropath-
ogenic effect may then be triggered by hyperos-
molarity, a change in the reductive–oxidative
state, reduced nitric oxide synthesis, or vascular
dysfunction.22
Our results indicated that autonomic neu-
ropathy was more likely to occur with extended
DD in type 1 diabetes. This finding was consistent
with an early report by Valensi et al, which showed
that the prevalence of CAN was correlated with 
diabetic duration.23 Rollins et al also reported a
similar result of the mean HRV in patients with
DD > 3 years being significantly lower in com-
parison with control subjects.20 A significant cor-
relation between DD and LnHF rather than LnLF
was observed in our study, which implied that the
early impairment of the autonomic nervous sys-
tem in diabetes lay mainly in the parasympathetic
component.10,24 The long-term effect of diabetes
on HRV has been reported by Burger et al who
investigated HRV in 23 diabetic patients with a
DD > 24 years.25 In their series, all of the HRV
parameters were markedly decreased in compari-
son with the normal controls, which might imply
further deterioration of parasympathetic activity
or the overall involvement of the autonomic
nervous system.
The major purpose of our study was to exam-
ine the concurrent influence of HbA1C and DD
on HRV in type 1 diabetes. Based on the results
of a series of multiple regression analyses, it was
demonstrated that HbA1c was a more dominant
predictor in LnTP, LnHF and LnLF than DD. In
addition, subjects were classified into four groups
according to their glycemic control and DD. The
results indicated that children with HbA1c > 8%
and DD > 4.5 years were more likely to be affected
by CAN. The HRV of the remaining three groups,
however, did not significantly differ at rest. These
findings suggest that no matter how long the DD,
early and intensive care in glycemic control is 
S.R. Chen, et al
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Figure 3. Comparison of heart rate variability parameters
among groups at rest and during exercise in children 
with type 1 diabetes: (A) LnLF; (B) LnHF; (C) LnTP.
*p < 0.05 vs. group IV at rest. Group I = HbA1c ≤ 8%, DD
≤ 4.5 years; Group II = HbA1c ≤ 8%, DD > 4.5 years; Group
III = HbA1c > 8%, DD ≤ 4.5 years; Group IV = HbA1c > 8%,
DD > 4.5 years.
a key factor for preventing the occurrence of CAN
in type 1 diabetes.
Although a normal cardiovascular response
to parasympathetic withdrawal resulting in in-
creased heart rate and greatly reduced HRV dur-
ing exercise in healthy populations have been
reported in previous studies,26,27 the changes in
HRV during exercise in diabetic patients have not
yet been elucidated. In our study, a similar result
in terms of a decrease in HRV during exercise was
observed and the smallest decrement in HRV from
resting to exercise was demonstrated in group IV
(HbA1c > 8%, DD > 4.5 years). However, no signif-
icant correlation between HbA1c and HRV or be-
tween DD and HRV was further observed during
exercise. Also, a significant difference in HRV
among the four groups was not demonstrated.
A short exercise for only 10 minutes and absolute
exercise intensity rather than relative exercise
intensity performed by each subject may have
contributed to these results. A recent study
conducted by Dewey et al revealed that greater
exercise-induced HRV during peak exercise was
related to increased risks for all-cause and cardio-
vascular mortality.28 These results contrast to those
found during rest. Therefore, it was suggested that
exercise draws out a different pattern of auto-
nomic and non-autonomic modulation. And it
is not easily accounted for by current explana-
tions for resting HRV. The response of HRV to ex-
ercise reflects their autonomic nervous function
and may be useful for finding patients who are 
at risk of subsequent mortality.
We conclude that at rest, HbA1c was a more
dominant predictor in LnTP, LnHF and LnLF
than DD in children with type 1 diabetes. HRV
reduced significantly from resting to exercise.
However, the responses of HRV during exercise
differ from the responses of HRV at rest.
The main limitation of the study was the use
of a single HbA1c test as an indicator of glycemic
control over DD. HbA1c reflects the average blood
sugar control for the past 2–3 months, and the av-
erage of a series of regular HbA1c tests would
have been more representative of overall glycemic
control. Nevertheless, the interval of HbA1c tests
usually depends on the clinical results of diabetic
control and a selection bias may still occur.
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